Skip to main content
Beilstein Journal of Organic Chemistry logoLink to Beilstein Journal of Organic Chemistry
. 2017 Jan 26;13:174–181. doi: 10.3762/bjoc.13.20

A novel method for heterocyclic amide–thioamide transformations

Walid Fathalla 1,, Ibrahim A I Ali 2, Pavel Pazdera 3
Editor: Brian Stoltz
PMCID: PMC5302013  PMID: 28228858

Abstract

In this paper, we introduce a novel and convenient method for the transformation of heterocyclic amides into heteocyclic thioamides. A two-step approach was applied for this transformation: Firstly, we applied a chlorination of the heterocyclic amides to afford the corresponding chloroheterocycles. Secondly, the chloroherocycles and N-cyclohexyl dithiocarbamate cyclohexylammonium salt were heated in chloroform for 12 h at 61 °C to afford heteocyclic thioamides in excellent yields.

Keywords: heterocyclic amides, heterocyclic thioamides, N-cyclohexyl dithiocarbamate cyclohexylammonium salt, novel thiating agent, thiation

Introduction

Transforming heterocyclic amides into thioamides is an important task in organic synthesis. Earlier reports for this type of O/S conversions were achieved by several thiating reagents; for instance, Lawesson's reagent (2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane 2,4-disulfide) [13], Berzelius reagent [46] (P4S10), and phosphorus pentasulfide [7] in dry toluene, xylene or pyridine under reflux conditions. A two-step approach for the purpose of thiation of heterocyclic amides attracted our attention: as a first step, we applied a chlorination of heterocyclic amides, followed by thiation via reaction with thiourea on the basis of reagent-promoted desulfurylation of isothiourea under strong basic conditions [89]. Aiming to continue our reseach work on the structure modification of functionalized heterocyclic amides and thioamides [1017], we found it interesting to design a new convenient and simple method for the thiation of heterocyclic amides.

Results and Discussion

Many synthetic methods related to thiation of heterocyclic amides have been reported to date. Most methods suffer from the employment of expensive specific reagents, high temperature, use of strong basic conditions, ultra-dry solvents, bad smell, low yield, difficulties in work-up procedures or from a narrow substrate scope. Therefore, the development of a more efficient method for the transformation of heterocyclic amides to heterocyclic thioamides gained great attention.

The reaction of three molar equivalents of cyclohexylamine (1) with one molar equivalent of carbon disulfide in water typically afforded N-cyclohexyl dithiocarbamate cyclohexylammonium salt (2) as an excellent new thiating reagent in high yield, Scheme 1.

Scheme 1.

Scheme 1

Synthesis of N-cyclohexyl dithiocarbamate cyclohexylammonium salt (2).

The structure assignment of the prepared N-cyclohexyl dithiocarbamate cyclohexylammonium salt (2) is based on 1H and 13C NMR spectral and physicochemical analysis. The 1H NMR spectrum displays a broad singlet signal at 8.01 ppm associated with three NH protons. The 1H NMR spectrum also shows three multiplet signals at 4.15–3.95 and 3.05–2.96 and 1.98–0.96 ppm corresponding to two CH and 10 CH2 groups, respectively. The 13C NMR spectrum of 2 displays signals at δ 212.4, 55.3 and 50.0 ppm associated with (C=S) and two CH groups, respectively. The 13C NMR spectrum of 2 also shows signals at 32.3, 30.9, 25.8, 25.5, 25.1, and 24.3 ppm due to cyclohexyl CH2 groups.

Heterocyclic amides A1–13 used in this context were prepared as described in literature expanding simple one-step procedures to multi-step sequential reactions. Quinazoline-4-one (A1) [18] was prepared by Niementowski reaction by fusion of anthranilic acid with formamide at 120 °C for 5 h. A number of quinazoline derivatives A2–A6 [1921] were prepared via sequential steps starting from easily available carboxylic acid chlorides. The acid chlorides reacted with anthranilic acid to afford benzoxazines, followed by sequential reaction with ammonia to afford the benzanilide derivatives and finally, benzanilides were cyclized by heating in sodium hydroxide solution and gave quinazolines A2–A6. Methyl 1,2-dihydro-2-oxoquinoline-4-carboxylate (A9) [2223] was prepared by heating isatine with malonic acid followed by esterification of the produced quinoline carboxylic acid with methanol in the presence of sulfuric acid at 80 °C for 6 h. 4-Arylphthalazin-1(2H)-ones A7 and A8 [2425] were prepared by Friedel–Crafts acylation reaction of N-aminophthalimide with either benzene or toluene in the presence of AlCl3, respectively. A number of quinoxalin-2-one derivatives A10–13 [2629] were prepared by the reaction of o-phenylenediamine with oxoacids or oxoesters either in HCl solution or in ethanol.

Heterocyclic amides A1–9 were heated with POCl3 for 2–5 h as reported in literature to afford the respective chloroheterocycles [3037] B1–9 and 13 and were purified using flash column chromatography; petroleum ether (60–80)/ethyl acetate (9:1) as an eluent. Best results for the preparation of chloroquinoxalinones B11 and B12 [3839] were achieved by dropwise addition of N,N-dimethylaniline to a stirred cold solution of quinoxalinones A11 and A12 and POCl3, the reaction mixture was refluxed for 15 minutes.

Thus, N-cyclohexyl dithiocarbamate cyclohexylammonium salt (2) was added to 4-chloro-2-phenylquinazoline (B2) solution in CHCl3, the reaction mixture was heated at 61 °C for 12 h. The reaction mixture was evaporated and poured in ethanol to give bright yellow crystals as only isolated product, identified as 2-phenylquinazoline-4(3H)-thione (C2). The filtrate was once again evaporated and crystalized from ethanol/water to give dicyclohexylthiourea (3, Scheme 2). We have extended the scope of this process to involve the transformation of a number of heterocyclic amides; quinazolin-4(3H)-one (A1), 2-substituted quinazolin-4(3H)-one A3–A6 and 4-subsituted phthalazin-1(2H)-ones A7 and A8 into the corresponding heterocyclic thioamides C1 and C3–C8, respectively (Scheme 2, Table 1 and Table 2).

Scheme 2.

Scheme 2

The two-step thiation of quinazolin-4-one A1–6 and phthalazin-1-ones A7 and A8.

Table 1.

Synthesis of quinazolin-4-thionesa.

No. heterocyclic
amide A
chloro-
heterocycles B
heterocyclic
thioamide C
Yieldb %

1 Inline graphic
A1
Inline graphic
B1
Inline graphic
C1
76%
2 Inline graphic
A2
Inline graphic
B2
Inline graphic
C2
92%
3 Inline graphic
A3
Inline graphic
B3
Inline graphic
C3
84%
4 Inline graphic
A4
Inline graphic
B4
Inline graphic
C4
89%
5 Inline graphic
A5
Inline graphic
B5
Inline graphic
C5
95%
6 Inline graphic
A6
Inline graphic
B6
Inline graphic
C6
81%

aReaction conditions: chloroheterocycles (20 mmol) and N-cyclohexyl dithiocarbamate cyclohexylammonium salt (2, 20 mmol) were heated in CHCl3 (25 mL) at 61 °C for 12 h. bYields refer to isolated pure product of the reaction from B to C.

Table 2.

Synthesis of phthalizin-1-thiones C7 and C8a.

No. heterocyclic
amide A
chloro-
heterocycles B
heterocyclic
thioamide C
Yieldb %

7 Inline graphic
A7
Inline graphic
B7
Inline graphic
C7
91%
8 Inline graphic
A8
Inline graphic
B8
Inline graphic
C8
78%

aReaction conditions as described before. bYields refer to isolated pure product of the reaction from B to C.

The N-cyclohexyl dithiocarbamate cyclohexylammonium salt (2) has been found to be an excellent reagent for thiation of heterocyclic amides into thioamides at position 4, Scheme 2, Table 1 and Table 2. We have extended the scope of this thiation process to involve heterocyclic amides at positions 2 and 3. Thus, methyl 1,2-dihydro-2-oxoquinoline-4-carboxylate (A9) and 3-substituted quinoxalin-2(1H)-ones A10–13 reacted similarly with phosphorous oxychloride to afford the chloro derivatives B9–13 which were subsequently converted into the corresponding thioamides C9–13 by the reaction with N-cyclohexyl dithiocarbamate cyclohexylammonium salt (2) in CHCl3 under reflux conditions for 12 h (Scheme 3, Table 3).

Scheme 3.

Scheme 3

Thiation of quinoline A9 and quinoxalinone A10–13.

Table 3.

Synthesis of quinolin-2-thiones C9 and quinoxalin-2-thiones C10–C13a.

No. heterocyclic
amide A
chloro-
heterocycles B
heterocyclic
thioamide C
Yieldb %

9 Inline graphic
A9
Inline graphic
B9
Inline graphic
C9
76%
10 Inline graphic
A10
Inline graphic
B10
Inline graphic
C10
69%
11 Inline graphic
A11
Inline graphic
B11
Inline graphic
C11
83%
12 Inline graphic
A12
Inline graphic
B12
Inline graphic
C12
72%
13 Inline graphic
A13
Inline graphic
B13
Inline graphic
C13
91%

aReaction conditions as described before. bYields refers to isolated pure product of the reaction from B to C.

The synthetic procedure for the formation of C1–13 reported herein have the advantage of operational simplicity and availability of both the substrate and the reagents giving a series of very interesting compounds. This method also was adjusted to involve a one-pot strategy starting from heterocyclic amides A1–13 to directly afford the heterocyclic thioamides C1–13. Thus, 2-phenylquinazolin-4(3H)-one (A2) was heated with phosphorous oxychloride for 2 h. The reaction mixture was evaporated and poured in ice-cold ammonia solution, then extracted with chloroform and dried over sodium sulfate. N-cyclohexyl dithiocarbamate cyclohexylammonium salt (2) was added to the chloroform solution of chloroquinazoline B2 and heated at 61 °C for 12 h. The reaction mixture was evapourated and ethanol was added successively to give the desired product C2.

The structure assignment of the prepared heterocyclic thioamides C1–13 is based on 1H and 13C NMR spectral and physicochemical analyses. The 1H NMR spectrum of 2-(4-methoxyphenyl)quinazoline-4(3H)-thione (C5) gave a broad singlet and a singlet signal at δ 13.71 and 3.87 ppm, associated with NH and OCH3 groups, respectively. The significant downfield shift of the NH proton is probably due to intermolecular hydrogen bond interactions of the type NH···S=C. All the isolated thioureas C1–13 exhibited similar 1H NMR spectral patterns with the NH protons at similar chemical shifts and they adopt paired thioamide structures (vide infra). The 1H NMR spectrum also shows four doublet and two triplet signals at δ 8.60, 8.19, 7.75, 7.11, 7.88, 7.56, respectively due to eight aromatic protons. The 13C NMR spectrum of C5 displays signals at δ 187.9 and 56.0 ppm due to C=S and OCH3, respectively.

A mechanistic rationalization for this interesting rearrangement is given in Scheme 4. The reaction of 4-chloro-2-phenylquinazoline (B2) with N-cyclohexyl dithiocarbamate cyclohexylammonium salt (2) in CHCl3 at 61 °C for 12 h was principally expected to give 2-phenylquinazolin-4-yl cyclohexylcarbamodithioate (I) and cyclohexylamine hydrochloride. Cyclohexylamine hydrochloride under heating conditions will eliminate an HCl molecule forming the free cyclohexylamine base.

Scheme 4.

Scheme 4

Rational mechanism of the reaction of 4-chloro-2-phenylquinazoline (B2) to 2-phenylquinazolin-4(3H)-thione.

Cyclohexylamine will further abstract a proton from I followed by electron delocalization and the overall formation of cyclohexyl isothiocyanate (4) via C–S bond cleavage and the formation of quinazoline thiol anion II having a negative charge concerted on the nitrogen atom. The protonated cyclohexylamine in the previous step will transfer this extra proton to II to afford the quinazoline thione C2. On the other hand the free cyclohexylamine will add to cyclohexyl isothiocyanate (4) to form the thiourea 3. Similar results were obtained by Furumoto [40], and Sun [41] reported the application of cyanuric chloride (2,4,6-trichloro-1,3,5-triazine, TCT) as a desulfurylation reagent in the synthesis of carbodiimides or alkyl isothiocyanates from thioureas under mild conditions.

Conclusion

Several synthetic procedures related to thiation of heterocyclic amides have been reported to date. The drawback of the existing methods is the use of expensive specific reagents, high temperature, use of strong basic conditions, ultra-dry solvents, bad smell, low yield, difficulties in work-up procedures or from a narrow substrate scope. In this work, we successfully developed a facile and convenient general method for the transformation of heterocyclic amides into heterocyclic thioamides. Generally, in the proposed technique we transformed heterocyclic amides to chloroheterocyclic compounds by the action of phosphorous oxychloride. Subsequently, chloroheterocyclic derivatives reacted with N-cyclohexyl dithiocarbamate cyclohexylammonium salt in chloroform at 61 °C for 12 h to finally afford the heterocyclic thioamides in excellent yields. Furthermore, this method is advantageous over existing methods in the matter of simplicity of the work-up procedure, higher yield, odorless, lower reaction temperature and finally the availability of both precursors and reagent.

Experimental

General procedures

Solvents were purified and dried by standard procedures. The boiling range of the petroleum ether used was 40–60 °C. Thin-layer chromatography (TLC): silica gel 60 F254 plastic plates (E. Merck, layer thickness 0.2 mm) detected by UV absorption. Elemental analyses were performed on a Flash EA-1112 instrument at the Microanalytical laboratory, Faculty of Science, Suez Canal University, Ismailia, Egypt. Melting points were determined on a Büchi 510 melting-point apparatus and the values are uncorrected. 1H and 13C NMR spectra were recorded at 300 MHz and 75.5 MHz, respectively (Bruker AC 300) in CDCl3 and DMSO solution with tetramethylsilane as an internal standard. The NMR analyses were performed at the Organic Chemistry Department Masaryk University, Brno, Czech Republic. Compounds A1–13 and B1–13 were obtained by published methods [1839], and their melting points and 1H and 13C NMR spectra corresponded to those given in the literature.

General method for the preparation of thiating reagent N-cyclohexyl dithiocarbamate cyclohexylammonium salt (2). To a mixture of freshly distilled cyclohexylamine (60 mmol) and water (50 mL) was added carbon disulfide (21 mmol) dropwise. The reaction mixture was stirred at room temperature for 2 h. The white solid obtained was filtered, washed with water, dried and crystalized from ethanol to provide the pure product. Yield 98% (ethanol 95%) white crystals, mp 188–189 °C; 1H NMR (300 MHz, DMSO-d6) δ 8.01 (bs, 3H, 3NH), 4.15–3.95 (m, 1H, CH), 3.05–2.96 (m, 1H, CH), 1.98–0.96 (20H, m, 10CH2); 13C NMR (75.0 MHz, DMSO-d6) δ 212.4 (C=S), 55.3 (CH), 50.0 (CH), 32.3 (2CH2), 30.9 (2CH2), 25.8 (CH2), 25.5 (2CH2), 25.1 (CH2), 24.3 (2CH2); anal. calcd for C13H26N2S2 (274.2): C, 56.56; H, 9.43; N, 10.09; found: C, 56.88; H, 9.55; N, 10.21.

General method for the preparation of heterocyclic thioamides

Method A. To a solution of chloroheterocycles (2.5 mmol) in CHCl3 (25 mL) was added (0.69 g, 2.5 mmol) of N-cyclohexyl dithiocarbamate cyclohexylammonium salt. The reaction mixture was refluxed at 61 °C for 12 h. The reaction mixture was evaporated under reduced pressure and 25 mL of ethanol was added to the solid residue. The yellowish–orange precipitate was filtered to give the desired product. The crude compounds were pure enough for analytical purposes. Purification of products for analysis was achieved by crystallization from the appropriate solvent; chromatographed with the appropriate eluent or by repeated dissolution in KOH and reprecipitation by acetic acid. The filtrate was evaporated once again and the solid obtained was crystalized from ethanol water to give symmetrical dicyclohexylthiourea (3).

Method B. To a cold solution of heterocyclic amide (2.5 mmol) in POCl3 (25 mL) was added dimethylaniline (2.5 mmol). The reaction mixture was stirred under reflux (100–105 °C) for 1.5–2 h. The excess POCl3 was removed under reduced pressure. The residue was poured into a mixture of chloroform (50 mL), ice water (80 mL) and ammonia (5 mL). The chloroform layer was separated, dried over Na2SO4 and filtered. To this chloroform solution of the in situ generated chloroheterocycles was added (0.69 g, 2.5 mmol) of N-cyclohexyl dithiocarbamate cyclohexylammonium salt. The reaction mixture was refluxed at 61 °C for 12 h. The reaction mixture was evaporated under reduced pressure and 25 mL of ethanol was added to the solid residue. The yellowish–orange precipitate was filtered to give the desired product. The crude compounds were pure enough for analytical purposes. Purification of products for analysis was achieved by crystallization from the appropriate solvent; chromatographed with the appropriate eluent or by repeated dissolution in KOH and reprecipitation by acetic acid.

Dicyclohexylthiourea (3) [42]: Yield 65% (ethanol 95%–H2O) white crystals, mp 180–181 °C; 1H NMR (300 MHz, DMSO-d6) δ 7.05 (bs, 2H, NH), 4.05–3.89 (m, 2H, 2CH), 1.87–1.52 (m, 10H, 5CH2) 1.29–1.12 (m, 10H, 5CH2); 13C NMR (75.0 MHz, DMSO-d6) δ 180.5 (C=S), 51.9 (CH), 32.8 (2CH2), 25.7 (2CH2), 25.0 (CH2); anal. calcd for C13H24N2S (240.2): C, 64.95; H, 10.06; N, 11.65; found: C, 64.82; H, 10.01; N, 11.46.

Quinazoline-4(3H)-thione (C1) [43]: Yield 76% (H2O) yellow crystals, mp 320–321 °C; 1H NMR (300 MHz, DMSO-d6) δ 13.83 (bs, 1H, NH), 8.55–7.28 (m, 5H, ArH); 13C NMR (75.0 MHz, DMSO-d6) δ 186.2 (C=S), 144.8 (C Ar), 144.2 (CHAr), 135.7 (CHAr), 129.7 (CHAr), 129.4 (C Ar), 128.7 (CHAr), 128.5 (CHAr); anal. calcd for C8H6N2S (162.0): C, 59.23; H, 3.73; N, 17.27; found: C, 59.17; H, 3.69; N, 17.15.

2-Phenylquinazoline-4(3H)-thione (C2) [44]: Yield 92% (ethanol 95%–DMF) yellow crystals, mp 222–223 °C; 1H NMR (300 MHz, DMSO-d6) δ 13.75 (bs, 1H, NH), 8.63 (d, J = 8.0 Hz, 1H, ArH), 8.17 (d, J = 8.0 Hz, 2H, ArH), 7.93–7.89 (m, 3H, ArH), 7.82–7.57 (m, 3H, ArH); 13C NMR (75.0 MHz, DMSO-d6) δ 188.5 (C=S), 152.1 (C Ar), 144.8 (C Ar), 135.8 (CHAr), 132.8 (C Ar), 131.9 (CHAr), 129.8 (CHAr), 128.9 (CHAr), 128.6 (CHAr), 128.4 (CHAr), 128.1 (C Ar); anal. calcd for C14H10N2S (238.1): C, 70.56; H, 4.23; N, 11.76; found: C, 70.48; H, 4.16; N, 11.49.

2-o-Tolylquinazoline-4(3H)-thione (C3) [45]: Yield 84% (ethanol 95%–DMF) yellow crystals, mp 183–184 °C; 1H NMR (300 MHz, DMSO-d6) δ 13.97 (bs, 1H, NH), 8.65 (d, J = 8.0 Hz, 1H, ArH), 7.96 (t, J = 8.0 Hz, 1H, ArH), 7.75 (d, J = 8.0 Hz, 1H, ArH), 7.66–7.35 (m, 5H, ArH), 2.39 (s, 3H, CH3); 13C NMR (75.0 MHz, DMSO-d6) δ 187.7 (C=S), 155.5 (C Ar), 144.7 (C Ar), 136.8 (C Ar), 135.8 (CHAr), 134.0 (CHAr), 130.9 (C Ar), 130.6 (CHAr), 130.0 (CHAr), 129.7 (CHAr), 128.6 (CHAr), 128.0 (CHAr), 126.1 (C Ar), 19.9 (CH3); anal. calcd for C15H12N2S (252.1): C, 71.40; H, 4.79; N, 11.10; found: C, 71.21; H, 4.65; N, 10.94.

2-p-Tolylquinazoline-4(3H)-thione (C4) [46]: Yield 89% (ethanol 95%–DMF) yellow crystals, mp 218–219 °C; 1H NMR (300 MHz, DMSO-d6) δ 13.78 (bs, 1H, NH), 8.62 (d, J = 8.0 Hz, 1H, ArH), 8.10 (d, J = 8.0 Hz, 2H, ArH), 7.93–7.76 (m, 2H, ArH), 7.58 (t, J = 8.0 Hz, 1H, ArH), 7.37 (d, J = 8.0 Hz, 2H, ArH), 2.41 (s, 3H, CH3); 13C NMR (75.0 MHz, DMSO-d6) δ 187.9 (C=S), 151.9 (C Ar), 149.3 (C Ar), 142.1 (C Ar), 135.9 (CHAr), 130.4 (C Ar), 129.8 (CHAr), 129.7 (CHAr), 129.6 (CHAr), 128.8 (CHAr), 126.3 (CHAr), 128.0 (CHAr), 126.4 (C Ar), 21.5 (CH3); anal. calcd for C15H12N2S (252.1): C, 71.40; H, 4.79; N, 11.10; found: C, 71.28; H, 4.61; N, 11.84.

The yield, 1H, 13C NMR spectral data and physicochemical analysis of other prepared thioamides (C5C13) are presented in Supporting Information File 1.

Supporting Information

File 1

Additional experimental and analytical data.

Acknowledgments

We would like to thank the Department of Organic Chemistry, Faculty of Science, Masaryk University, Brno, Czech Republic and the Ministry of high education Egypt for funding this research proposal. We would like to thank Dr. Hewayda El-Ghawalby for technical support.

This article is dedicated to my late dearest professors, Faisal El-Oreeny and Tayseer Abdelrassool.

References

  • 1.Ozturk T, Ertas E, Mert O. Chem Rev. 2007;107:5210. doi: 10.1021/cr040650b. [DOI] [PubMed] [Google Scholar]
  • 2.Ozturk T, Ertas E, Mert O. Chem Rev. 2010;110:3419. doi: 10.1021/cr900243d. [DOI] [PubMed] [Google Scholar]
  • 3.Curphey T J. J Org Chem. 2002;67:6461. doi: 10.1021/jo0256742. [DOI] [PubMed] [Google Scholar]
  • 4.Libermann R. Bull Soc Chim Fr. 1959:1793. [Google Scholar]
  • 5.Leonard N J, Curtin D Y. J Org Chem. 1946;11:349. doi: 10.1021/jo01174a007. [DOI] [PubMed] [Google Scholar]
  • 6.Armstrong R T, inventor. Vulcanization accelerators. US2382769. U.S. Patent. 1945 Aug 14;
  • 7.Morrison D C, Furst A. J Org Chem. 1956;21:470. doi: 10.1021/jo01110a026. [DOI] [Google Scholar]
  • 8.Asano K. Yakugaku Zasshi. 1958;78:729. [Google Scholar]
  • 9.El-Hawash S A M, Abdel Wahab A E. Arch Pharm. 2006;339:437. doi: 10.1002/ardp.200600012. [DOI] [PubMed] [Google Scholar]
  • 10.Fathalla W, Čajan M, Pazdera P. Molecules. 2000;5:1210. doi: 10.3390/51201210. [DOI] [Google Scholar]
  • 11.Fathalla W, Čajan M, Pazdera P. Molecules. 2001;6:557. doi: 10.3390/60600557. [DOI] [Google Scholar]
  • 12.Fathalla W, Pazdera P, Marek J. J Heterocycl Chem. 2002;39:1139. doi: 10.1002/jhet.5570390605. [DOI] [Google Scholar]
  • 13.Fathalla W, Marek J, Pazdera P. J Sulfur Chem. 2008;29:31. doi: 10.1080/17415990701759685. [DOI] [Google Scholar]
  • 14.Fathalla W. ARKIVOC. 2008;xii:245. [Google Scholar]
  • 15.Ali I A I, Fathalla W. Heteroat Chem. 2006;17:280. doi: 10.1002/hc.20203. [DOI] [Google Scholar]
  • 16.Fathalla W, El Rayes S, Ali I A I. ARKIVOC. 2008;xiii:179. [Google Scholar]
  • 17.Fathalla W. Chem Heterocycl Compd. 2015;51:67. doi: 10.1007/s10593-015-1661-1. [DOI] [Google Scholar]
  • 18.Yamamoto Y. ((Science of Synthesis: Houben-Weyl)).Methods of molecular hetarenes and related ring systems. 2003;16:726. [Google Scholar]
  • 19.Sundaram R, Yuvaraj E, Babu G. Indian J Chem, Sect B: Org Chem Incl Med Chem. 1999;38:905. [Google Scholar]
  • 20.Lee E S, Son J K, Na Y H, Jahng Y. Heterocycl Commun. 2004;10:325. doi: 10.1515/HC.2004.10.4-5.325. [DOI] [Google Scholar]
  • 21.Okada K, Sakuma H, Inoue S. Chem Lett. 1979;8:131. doi: 10.1246/cl.1979.131. [DOI] [Google Scholar]
  • 22.Chawla H M, Gupta T. J Inclusion Phenom Macrocyclic Chem. 2015;81:49. doi: 10.1007/s10847-014-0432-4. [DOI] [Google Scholar]
  • 23.Derbala H A Y. Indian J Chem, Sect B: Org Chem Incl Med Chem. 1994;33:779. [Google Scholar]
  • 24.Ismail M F, Kandile N G. Acta Chim Hung. 1991;128:251. [Google Scholar]
  • 25.Ajani O O, Obafemi C A, Ikpo C O, Ogunniran K O, Nwinyi O C. Chem Heterocycl Compd. 2009;45:1370. doi: 10.1007/s10593-010-0435-z. [DOI] [Google Scholar]
  • 26.Noolvi M N, Patel H M, Bhardwaj V, Chauhan A. Eur J Med Chem. 2011;46:2327. doi: 10.1016/j.ejmech.2011.03.015. [DOI] [PubMed] [Google Scholar]
  • 27.Mahesh R, Dhar A K, Sasank T V N V T, Thirunavukkarasu S, Devadoss T. Chin Chem Lett. 2011;22:389. doi: 10.1016/j.cclet.2010.11.002. [DOI] [Google Scholar]
  • 28.Elhelby A A, Ayyad R R, Zayed M F. Arzneim Forsch. 2011;61:379. doi: 10.1055/s-0031-1296214. [DOI] [PubMed] [Google Scholar]
  • 29.Shi L, Wu T-T, Wang Z, Xu J-Y, Xu Y-G. Bioorg Med Chem. 2014;22:4735. doi: 10.1016/j.bmc.2014.07.008. [DOI] [PubMed] [Google Scholar]
  • 30.Marvania B, Lee P-C, Chaniyara R, Dong H, Suman S, Kakadiya R, Chou T-C, Lee T-C, Shah A, Su T-L. Bioorg Med Chem. 2011;19:1987. doi: 10.1016/j.bmc.2011.01.055. [DOI] [PubMed] [Google Scholar]
  • 31.Aly A A. J Chin Chem Soc. 2007;54:437. doi: 10.1002/jccs.200700061. [DOI] [Google Scholar]
  • 32.Browner M, Clark D, Cushing T, Hao X, Hawley R, He X, Jaen J, Lebadie S, Smith M-L, Talmas F, et al., inventors. Antiinflammation agents. US 20020161004 A1. U.S. Pat. Appl. 2002 Oct 31;
  • 33.Rival Y, Hoffmann R, Didier B, Rybaltchenko V, Bourguignon J, Wermuth C G. J Med Chem. 1998;41:311. doi: 10.1021/jm9705418. [DOI] [PubMed] [Google Scholar]
  • 34.Hemdan M M, Taha S M, Gabr A M, Elkady M Y. J Chem Res. 2010;34:102. doi: 10.3184/030823410X12658886079090. [DOI] [Google Scholar]
  • 35.Galal S A, Abdelsamie A S, Tokuda H, Suzuki N, Lida A, ElHefnawi M M, Ramadan R A, Atta M H E, El Diwani H I. Eur J Med Chem. 2011;46:327. doi: 10.1016/j.ejmech.2010.11.022. [DOI] [PubMed] [Google Scholar]
  • 36.Da Silva Miranda F, Signori A M, Vicente J, De Souza B, Priebe J P, Szpoganicz B, Gonçalves N S, Neves A. Tetrahedron. 2008;64:5410. doi: 10.1016/j.tet.2008.02.097. [DOI] [Google Scholar]
  • 37.Aggarwal R, Masan E, Sumran G. Synth Commun. 2013;43:1842. doi: 10.1080/00397911.2012.674168. [DOI] [Google Scholar]
  • 38.Wagle S, Adhikari A V, Kumari N S. Eur J Med Chem. 2009;44:1135. doi: 10.1016/j.ejmech.2008.06.006. [DOI] [PubMed] [Google Scholar]
  • 39.Koshel N G, Kovalev E G, Postovskii I Ya. Chem Heterocycl Compd. 1970;6:791. doi: 10.1007/BF00470545. [DOI] [Google Scholar]
  • 40.Furumoto S. Nippon Kagaku Zasshi. 1971;92:1005. doi: 10.1246/nikkashi1948.92.1005. [DOI] [Google Scholar]
  • 41.Sun N, Li B, Shao J, Mo W, Hu B, Shen Z, Hu X. Beilstein J Org Chem. 2012;8:61. doi: 10.3762/bjoc.8.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Ramadas K, Janarthanan N, Velmathi S. Synth Commun. 1997;27:2255. doi: 10.1080/00397919708003379. [DOI] [Google Scholar]
  • 43.Sánchez A I, Martinez-Barrasa V, Burgos C, Vaquero J J, Alvarez-Builla J, Terricabras E, Segarra V. Bioorg Med Chem. 2013;21:2370. doi: 10.1016/j.bmc.2013.01.067. [DOI] [PubMed] [Google Scholar]
  • 44.Lee N K, Lee J W, Lee S, Im G-J, Han H Y, Kim T K, Kwak W-j, Kim S W, Ha J, Kim E K, et al., inventors. Quinazoline derivatives for the treatment and prevention of diabetes and obesity. US20080207614 A1. U.S. Pat. Appl. 2008 Aug 28;
  • 45.Legrand L. Bull Soc Chim Fr. 1961:620. [Google Scholar]
  • 46.Hanusek J, Hejtmánková L, Kubicová L, Sedlák M. Molecules. 2001;6:323. doi: 10.3390/60400323. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

File 1

Additional experimental and analytical data.


Articles from Beilstein Journal of Organic Chemistry are provided here courtesy of Beilstein-Institut

RESOURCES